Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san francisco blog main
5
×
boston blog main
boston top stories
gene editing
national top stories
san francisco top stories
biotech
boston
crispr
editas medicine
crispr therapeutics
crispr-cas9
deals
enzyme
feng zhang
intellia therapeutics
abbvie
agios therapeutics
allergan
alzheimer's disease
base editing
branden moriarty
broad institute
cancer
cas13
clinical study
clinical trials
cynthia collins
data
david liu
david walt
diagnostics
disease
dna
editas
editor
editr
gag
What
editing
5
×
gene
5
×
crispr
medicine
cas
editas
genetic
human
medicines
therapeutics
abbvie
alliance
beam
benefit
bio
biotech
cancer
cells
create
defect
diagnostic
diseases
drive
edited
editor
exits
experimental
fears
fix
flag
founders
going
gotten
guardian
harvard
heats
high
humans
isn't
jump
Language
unset
Current search:
editing
×
gene
×
" san francisco blog main "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M